The patient is an 84 year old woman having [a] medical history of cerebral infraction and fracture of the femur. In September 1998, ascites and edema were found and the possibility of ovarian or uterine cancer was suggested by the ascites and high level of CA-125.
AHCC oral administrations started from December 4, 1998 (3g/day) subsequently increased her appetite and two months later decreased her edema, and the ascites were not detected by the middle of February, 1999. Furthermore, CA-125 went down from 450 U/ml to 32 U/ml and her performance status improved to PS-II from PS-IV. Cause of the ascites and high level of CA-125 may be benign disease of peritoneal, that is, occlusion of mesenteric artery by arteriosclerosis. From a point of view described above, AHCC can help improve QOL (quality of life) of patients.
AHCC oral administrations started from December 4, 1998 (3g/day) subsequently increased her appetite and two months later decreased her edema, and the ascites were not detected by the middle of February, 1999. Furthermore, CA-125 went down from 450 U/ml to 32 U/ml and her performance status improved to PS-II from PS-IV. Cause of the ascites and high level of CA-125 may be benign disease of peritoneal, that is, occlusion of mesenteric artery by arteriosclerosis. From a point of view described above, AHCC can help improve QOL (quality of life) of patients.
- Susumu Konda, Uchinada-onsen Hospital, Japan
